Clinicopathological significance of PTEN and caspase-3 expressions in breast cancer

Chinese Medical Sciences Journal

Volumn 23, Issue 2, 2008, Pages 95-102

  Yang, Xue Fei ^a   Xin, Yan ^a   Mao, Li Li ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Caspase 3; Prognosis; PTEN; Tumor suppressor gene

Indexed keywords

CASPASE 3; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

EID: 47349094963     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-9294(09)60019-5     Document Type: Article

References (23)

1. Petrocelli T, Slingerland JM. PTEN deficiency: a role in mammary carcinogenesis. Breast Cancer Res 2001; 3:356-60.
2. Faucherre A, Taylor GS, Overvoorde J, et al. Zebrafish pten genes have overlapping and non-redundant functions in tumorigenesis and embryonic development Oncogene 2008; 27:1079-86.
3. Scheper MA, Nikitakis NG, Sarlani E, et al. Cowden syndrome: report of a case with immunohistochemical analysis and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101:625-31.
4. Torres J, Rodriguez J, Myers MP, et aL Phosphorylation-related cleavage of the tumor suppressor PTEN by caspase-3: implications for the control of protein stability and PTEN-protein interactions. J Biol Chem 2003; 278:30652-60.
5. Bose S, Crane A, Hibshoosh H, et al. Reduced expression of PTEN correlates with breast cancer progression. Hum Pathol 2002; 33:405-9.
6. Depowski PL, Rosenthal SI, Ross JS. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer. Mod Pathol 2001; 14:672-6.
7. Perez-Tenorio G, Alkhori LM Olsson B, Waltersson MA, et al. PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer. Clin Cancer Res 2007; 13:3577-84.
8. Sansal I, Sellers WR. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 2004; 22:2954-63.
9. Jesionek-Kupnicka D, Kulczycka D, Rieske P, et al. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course. Pol J Pathol 2007; 58:79-85.
10. Stacker H, Andjelkovic M, Oldham S, et al. Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB. Science 2002; 295:2088-91.
11. Weng LP, Brown JL, Baker KM, et al. PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway. Hum Mol Genet 2002; 11:1687-96.
12. Marino M, Acconcia F, Trentalance A. Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol Biol Cell 2003; 14:2583-91.
13. Jones G, Machado J Jr, Tolnay M, et al. PTEN-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors which highly express focal adhesion kinase (FAK). Cancer Res 2001; 61:5688-91.
14. Gu J, Tamura M, Pankov R, et al. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 1999;146:389-403.
15. Zhang R, Banik NL, Ray SK Combination of all-trans retinoic acid and interferon-gamma suppressed PDK/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in flioblastoma U87MG cells for induction of apoptosis. Neurochem Res 2007; 32:2194-202.
16. Zhao T, Adams MH, Zou SP, et al Silencing the PTEN gene is protective against neuronal death induced by human immunodeficiency virus type 1 Tat J Neurovirol 2007; 13:97-106.
17. Chung MJ, Jung SH, Lee BJ, et al. Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer. Pathol Int 2004; 54:10-5.
18. Park HJ, Kim YJ, Leem K, et al. Coptis japonica root extract induces apoptosis through caspase3 activation in SNU-668 human gastric cancer cells. Phytother Res 2005; 19:189-92.
19. Kang-Park S, Im JH, Lee JH, et al. PTEN modulates hepatitis B virus-X protein induced survival signaling in Chang liver cells. Virus Res 2006; 122:53-60.
20. Gomez-Gutierrez JG, Souza V, Hao HY, et al. Adenovirus-mediated gene transfer of FKHRLl triple mutant efficiently induces apoptosis in melanoma cells. Cancer Biol Ther 2006; 5: 875-83.
21. Rice KM, Desai DH, Kakarla SK, et al Diabetes alters vascular mechanotransduction: pressure-induced regulation of mitogen activated protein kinases in the rat inferior vena cava. Cardiovasc Diabetol 2006; 5:18.
22. Schwartzbauer G, Robbins J. The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J Biol Chem 2001; 276:35786-93.
23. Pourmand G, Ziaee AA, Abedi AR, et al. Role of PTEN gene in progression of prostate cancer. Urol J 2007; 4:95-100.